Columbus Circle Investors’s Zimmer Biomet ZBH Stock Holding History

Columbus Circle Investors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,437	Closed	-$2.44M	–	194
2020 Q3	$2.44M	Sell	18,437 -52,158	-74%	-$6.81M	0.11%	129
2020 Q2	$8.18M	Buy	70,595 +30,322	+75%	+$3.49M	0.33%	103
2020 Q1	$3.95M	Sell	40,273 -7,032	-15%	-$922K	0.22%	124
2019 Q4	$6.87M	Buy	+47,305	New	+$6.53M	0.3%	109
2016 Q4	–	Sell	-142,900	Closed	-$18M	–	304
2016 Q3	$18M	Sell	142,900 -52,834	-27%	-$6.53M	0.19%	105
2016 Q2	$22.9M	Buy	+195,734	New	+$22.2M	0.23%	110
2015 Q1	–	Sell	-161,951	Closed	-$17.8M	–	330
2014 Q4	$17.8M	Buy	161,951 +31,235	+24%	+$3.29M	0.13%	152
2014 Q3	$12.8M	Sell	130,716 -211,526	-62%	-$20.8M	0.09%	179
2014 Q2	$34.5M	Buy	+342,242	New	+$33.4M	0.24%	105

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Columbus Circle Investors's ZBH Position: Q4 2020 in Review

Columbus Circle Investors sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 18,437 shares — an estimated $2.44M sold.

Columbus Circle Investors first reported a position in ZBH in Q2 2014 and held it in 9 quarters. The position peaked at $34.5M in Q2 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

Columbus Circle Investors reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
Columbus Circle Investors sold 18,437 Zimmer Biomet shares in Q4 2020, an estimated $2.44M.
Columbus Circle Investors first reported a position in Zimmer Biomet in Q2 2014 and held it in 9 quarters.
Columbus Circle Investors's Zimmer Biomet position peaked at $34.5M in Q2 2014.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.